Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2

Status

Completed 5Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Gynecologic 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 6Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Stomach Neoplasms 2Neoplasm Metastasis 2Melanoma 2Head and Neck Neoplasms 2Disease 2Colonic Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Vasculitis 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Osteomyelitis 1Nose Neoplasms 1Myelodysplastic Syndromes 1Multiple Pulmonary Nodules 1

Interventions

Prednisone 112Docetaxel 87Leuprolide 79enzalutamide 72Abiraterone Acetate 67bicalutamide 53Goserelin 50acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42Radiotherapy 39abiraterone 28Magnetic Resonance Spectroscopy 27Gonadotropin-Releasing Hormone 24gallium 68 PSMA-11 23apalutamide 22Androgen Antagonists 22luprolide acetate gel depot 21sipuleucel-T 20Radiosurgery 20Triptorelin Pamoate 18cabazitaxel 17cabozantinib 16Radiotherapy, Intensity-Modulated 16Flutamide 16pembrolizumab 15radium Ra 223 dichloride 14Prednisolone 14Nivolumab 14Dutasteride 14Dexamethasone 14Radiation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Prostatic Neoplasms × Positron-Emission Tomography × Clear all
NCT05470699 2026-06-02

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

City of Hope Medical Center

Phase NA Active not recruiting
34 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT04186845 2025-09-22

Spotlight

Blue Earth Diagnostics

Phase 3 Completed
391 enrolled 30 charts
Genitourinary

Disease, Prostatic Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Blue Earth Diagnostics

Phase 3 Completed
356 enrolled 28 charts
Genitourinary

Disease, Prostatic Neoplasms

NCT02611882 2020-12-22

PSMA PET

University of California, San Francisco

Phase 2 Completed
225 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT01205646 2019-04-12

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer

Barbara Ann Karmanos Cancer Institute

Phase NA Completed
11 enrolled 7 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡